Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 153 participants.

Also called NCT01049919

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 153 participants (enrolled count) (from the registry)
Sponsor
Zimmer Biomet (from the registry)
Registry
  • NCT NCT01049919
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01049919. Randomized; double masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2016-06 (actual). Results posted on 2021-05-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
Acronym
MOBILE
Condition
Critical Limb Ischemia
Condition
Peripheral Arterial Disease
Condition
Peripheral Vascular Disease
Intervention (Device)
Bone marrow concentration device
Intervention (Procedure)
Placebo procedure (sham)
Lead sponsor
Zimmer Biomet (class: industry)

Record details

Record id
cardio:ct-nct01049919
Content hash
f16632290bb8fca2e77289e61fcaf36223f811a6fab7969bc4df9e09cfcb9059